Department of Ophthalmology, Queen Fabiola Children's University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
The Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
Pediatr Nephrol. 2022 Oct;37(10):2361-2368. doi: 10.1007/s00467-022-05455-y. Epub 2022 Feb 3.
Rare autopsy studies have described smaller kidneys as well as urinary tract anomalies in Down syndrome. This observation has never been investigated in vivo and little is known about the possible consequences upon kidney function. Here we wish to confirm whether children with Down syndrome have smaller kidneys and to evaluate their kidney function in vivo.
This retrospective cohort study enrolled 49 children with Down syndrome, as well as 49 age- and sex-matched controls at the Queen Fabiola Children's University Hospital in Brussels, Belgium. Doppler and kidney ultrasonography, spot urine albumin to creatinine ratio, estimated glomerular filtration rate (eGFR), and anthropometric data were recorded.
Kidney size in children with Down syndrome was smaller than age- and sex-matched controls in terms of length (p < 0.001) and volume (p < 0.001). Kidney function based on eGFR was also decreased in Down syndrome compared to historical normal. Twenty-one of the children with Down syndrome (42%) had eGFR < 90 mL/min/1.73 m, with 5 of these (10%) having an eGFR < 75 mL/min/1.73 m. In addition, 7 of the children with Down syndrome (14%) had anomalies of the kidney and/or urinary tract that had previously been undiagnosed.
Children with Down syndrome have significantly smaller kidneys than age-matched controls as well as evidence of decreased kidney function. These findings, in addition to well-noted increased kidney and urologic anomalies, highlight the need for universal anatomical and functional assessment of all individuals with Down syndrome. A higher resolution version of the Graphical abstract is available as Supplementary information.
罕见的尸检研究表明唐氏综合征患者的肾脏较小,且尿路异常。这种观察结果从未在体内进行过研究,对于其对肾功能可能造成的影响知之甚少。在此,我们希望确认唐氏综合征患儿的肾脏是否较小,并评估其体内的肾功能。
这是一项在比利时布鲁塞尔的法比奥拉皇后儿童医院进行的回顾性队列研究,共纳入 49 名唐氏综合征患儿和 49 名年龄和性别匹配的对照组。记录了多普勒和肾脏超声、尿液白蛋白/肌酐比值、估算肾小球滤过率(eGFR)以及人体测量学数据。
唐氏综合征患儿的肾脏长度(p<0.001)和体积(p<0.001)均小于年龄和性别匹配的对照组。与历史正常相比,唐氏综合征患儿的基于 eGFR 的肾功能也降低。21 名唐氏综合征患儿(42%)的 eGFR<90mL/min/1.73 m,其中 5 名(10%)的 eGFR<75mL/min/1.73 m。此外,7 名唐氏综合征患儿(14%)存在先前未诊断出的肾脏和/或泌尿道异常。
唐氏综合征患儿的肾脏明显小于年龄匹配的对照组,且肾功能下降。这些发现,加上众所周知的增加的肾脏和泌尿科异常,强调了对所有唐氏综合征患者进行全面的解剖学和功能评估的必要性。